Platinum-Based Chemotherapy for Advanced-Stage Serous Ovarian Carcinoma of Low Malignant Potential

Author： Barakat R.R. Benjamin I. Lewis Jr. J.L. Saigo P.E. Curtin J.P. Hoskins W.J.

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.59, Iss.3, 1995-12, pp. : 390-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Use of Paclitaxel and Platinum-Based Chemotherapy in Uterine Papillary Serous Carcinoma

By Zanotti K.M. Belinson J.L. Kennedy A.W. Webster K.D. Markman M.

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 272-277

Elsevier

Access to resources Recommend Favorite

TP53 oncomorphic mutations predict resistance to platinum and taxanebased standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 607-618

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel-Anthracycline Combination Chemotherapy in Relapsing Advanced Ovarian Cancer after Platinum-Based Chemotherapy: A Pilot Study

By Kurtz J.E. Deplanque G. Duclos B. Eichler F. Giron C. Limacher J.M. Herbrecht R. Maloisel F. Oberling F. Bergerat J.P. Dufour P.

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 414-417

Elsevier

Access to resources Recommend Favorite

Taxol as Second-Line Treatment in Patients with Advanced Ovarian Cancer after Platinum-Based First-Line Chemotherapy

By Mayerhofer K. Kucera E. Zeisler H. Speiser P. Reinthaller A. Sevelda P.

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 109-113

Elsevier

Access to resources Recommend Favorite

"MECCA": A Developmental, Dose-Intensive, Non-Cross-Resistant Platinum-Based Chemotherapy for Advanced Ovarian Cancer

By Hoskins P.J. Swenerton K.D. Pike J.A. Mcmurtrie E.M. Lee N.

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 345-351

Academic Press

Access to resources Recommend Favorite